Summary & Overview
CPT 62165: Endoscopic Transnasal Transsphenoidal Pituitary Tumor Resection
CPT code 62165 represents endoscopic transnasal transsphenoidal resection of pituitary tumors using a neuroendoscope. This procedure is a minimally invasive neurosurgical approach to remove abnormal pituitary growths through the nasal cavity or sphenoidal sinuses, and it plays an important role in treating pituitary adenomas and other sellar lesions that affect endocrine and neurologic function. Nationally, this code matters because it captures a complex, resource-intensive operative service with implications for surgical scheduling, facility requirements, and perioperative care pathways.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of the clinical context for 62165, the typical site of service, and the service type. The publication also provides benchmarking and reimbursement context where available, summaries of common modifiers, and notes on coding relationships and policy updates affecting endoscopic pituitary surgery reimbursement. This information is intended for billing professionals, surgical program managers, and policy analysts seeking a national-level summary of clinical and billing considerations linked to CPT code 62165.
Data not available in the input for associated taxonomies, specific ICD-10 pairings, and payer-specific fee schedules.
Billing Code Overview
CPT code 62165 describes a neurosurgical procedure in which a small neuroendoscope is used to access the pituitary gland to remove an abnormal growth. The provider approaches the pituitary through the nasal cavity or the sphenoidal sinuses.
-
Service type: Endoscopic transnasal transsphenoidal pituitary tumor resection
-
Typical site of service: Operating room or ambulatory surgery center, with intraoperative endoscopic equipment and neurosurgical support
Clinical & Coding Specifications
Clinical Context
A typical patient is a 45-year-old adult presenting with progressive headaches, visual field deficits (classically bitemporal hemianopsia), and hormonal abnormalities such as hyperprolactinemia or secondary hypogonadism. Neuroimaging (MRI pituitary with contrast) demonstrates a pituitary macroadenoma centered in the sella turcica with suprasellar extension. Endocrinology evaluation documents hormonal dysfunction and neurosurgical consultation recommends surgical resection. The clinical workflow includes preoperative endocrine optimization and vision assessment, pre‑anesthesia evaluation, intraoperative neuronavigation and endoscopic transnasal transsphenoidal approach using a neuroendoscope to access the sphenoid sinus and sella, tumor debulking or gross total resection, reconstruction of the skull base as needed, and postoperative monitoring in a PACU or neurosurgical step‑down unit with endocrine and ophthalmologic follow‑up. Typical site of service is an inpatient hospital operating room or ambulatory surgery center when appropriate. The service type is a neurosurgical endoscopic transnasal transsphenoidal pituitary surgery coded by 62165.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required is substantially greater than typically required for 62165 due to complexity (extensive tumor adhesion, prolonged operative time) and fully documented. |